Can chronic gastritis cause an increase in fecal calprotectin concentrations?

被引:24
作者
Montalto, Massimo [1 ]
Gallo, Antonella [1 ]
Ianiro, Gianluca [1 ]
Santoro, Luca [1 ]
D'Onofrio, Ferruccio [1 ]
Ricci, Riccardo [2 ]
Cammarota, Giovanni [1 ]
Covino, Marcello [1 ]
Vastola, Monica [1 ]
Gasbarrini, Antonio [1 ]
Gasbarrini, Giovanni [1 ]
机构
[1] Catholic Univ, Inst Internal Med, I-00168 Rome, Italy
[2] Catholic Univ, Inst Pathol, I-00168 Rome, Italy
关键词
Chronic gastritis; Fecal calprotectin; Intestinal inflammation; Neutrophils; INFLAMMATORY-BOWEL-DISEASE; INTESTINAL INFLAMMATION; PROTEIN CALPROTECTIN; MARKER; LACTOFERRIN; IBD;
D O I
10.3748/wjg.v16.i27.3406
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To evaluate fecal calprotectin concentrations (FCCs) in subjects with chronic gastritis and the correlation between FCCs and gastritis activity score. METHODS: FCCs were measured in 61 patients with histological diagnosis of gastritis and in 74 healthy volunteers. Histological grading of gastritis was performed according to the updated Sydney gastritis classification. Patients were subdivided into 2 groups according to the presence/absence of an active gastritis. Patients with chronic active gastritis were divided into 3 subgroups on the basis of the activity score (mild, moderate, marked). FFCs in relation to Helicobacter pylori (H. pylon) infection and proton pump inhibitor (PPI) use were also evaluated. RESULTS: FCCs in patients with chronic active gastritis were not significantly different to FCCs either in subjects with non active gastritis or in healthy controls. Among patients with chronic active gastritis (even marked), FCCs did not significantly differ according to activity score. No significant differences in FCCs were found when considering H. pylori, as well as when considering PPI chronic use. CONCLUSION: FCCs were not significantly increased in subjects with chronic gastritis, even in those patients with a marked neutrophil infiltration. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码:3406 / 3410
页数:5
相关论文
共 23 条
[1]   DISTRIBUTION OF MACROPHAGES AND GRANULOCYTES EXPRESSING L1 PROTEIN (CALPROTECTIN) IN HUMAN PEYERS-PATCHES COMPARED WITH NORMAL ILEAL LAMINA PROPRIA AND MESENTERIC LYMPH-NODES [J].
BJERKE, K ;
HALSTENSEN, TS ;
JAHNSEN, F ;
PULFORD, K ;
BRANDTZAEG, P .
GUT, 1993, 34 (10) :1357-1363
[2]   Role of faecal calprotectin as non-invasive marker of intestinal inflammation [J].
Costa, F ;
Mumolo, MG ;
Bellini, M ;
Romano, MR ;
Ceccarelli, L ;
Arpe, P ;
Sterpi, C ;
Marchi, S ;
Maltinti, G .
DIGESTIVE AND LIVER DISEASE, 2003, 35 (09) :642-647
[3]   Classification and grading of gastritis - The updated Sydney System [J].
Dixon, MF ;
Genta, RM ;
Yardley, JH ;
Correa, P ;
Batts, KP ;
Dahms, BB ;
Filipe, MI ;
Haggitt, RC ;
Haot, J ;
Hui, PK ;
Lechago, J ;
Lewin, K ;
Offerhaus, JA ;
Price, AB ;
Riddell, RH ;
Sipponen, P ;
Solcia, E ;
Watanabe, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) :1161-1181
[4]   Fecal calprotectin:: A quantitative marker of colonic inflammation in children with inflammatory bowel disease [J].
Fagerberg, Ulrika Lorentzon ;
Loof, Lars ;
Lindholm, Johan ;
Hansson, Lars-Olof ;
Finkel, Yigael .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 45 (04) :414-420
[5]   Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease [J].
Gisbert, J. P. ;
McNicholl, A. G. .
DIGESTIVE AND LIVER DISEASE, 2009, 41 (01) :56-66
[6]   Fecal Calprotectin and Lactoferrin for the Prediction of Inflammatory Bowel Disease Relapse [J].
Gisbert, Javier P. ;
Bermejo, Fernando ;
Perez-Calle, Jose-Lazaro ;
Taxonera, Carlos ;
Vera, Isabel ;
McNicholl, Adrian G. ;
Algaba, Alicia ;
Lopez, Pilar ;
Lopez-Palacios, Natalia ;
Calvo, Marta ;
Gonzalez-Lama, Yago ;
Carneros, Jose-Antonio ;
Velasco, Marta ;
Mate, Jose .
INFLAMMATORY BOWEL DISEASES, 2009, 15 (08) :1190-1198
[7]  
Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113
[8]   Potential Anti-inflammatory Effects of Proton Pump Inhibitors: A Review and Discussion of the Clinical Implications [J].
Kedika, Ramalinga R. ;
Souza, Rhonda F. ;
Spechler, Stuart Jon .
DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (11) :2312-2317
[9]   Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs [J].
Luciani, F ;
Spada, M ;
De Milito, A ;
Molinari, A ;
Rivoltini, L ;
Montinaro, A ;
Marra, M ;
Lugini, L ;
Logozzi, M ;
Lozupone, F ;
Federici, C ;
Lessi, E ;
Parmiani, G ;
Arancia, G ;
Belardelli, F ;
Fais, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (22) :1702-1713
[10]   Fecal calprotectin in first-degree relatives of patients with ulcerative colitis [J].
Montalto, Massimo ;
Curigliano, Valentina ;
Santoro, Luca ;
Armuzzi, Alessandro ;
Cammarota, Giovanni ;
Covino, Marcello ;
Mentella, Maria C. ;
Ancarani, Francesca ;
Manna, Raffaele ;
Gasbarrini, Antonio ;
Gasbarrini, Giovanni .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (01) :132-136